Molecular characterization of hepatitis C virus

Current Studies in Hematology and Blood Transfusion

Volumn 62, Issue , 1998, Pages 1-37

  Reed, Karen E ^a   Rice, Charles M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALPHA INTERFERON; ANTIVIRUS AGENT; GANCICLOVIR; INDINAVIR; PROTEINASE INHIBITOR; RITONAVIR; SAQUINAVIR; SERINE PROTEINASE; STRUCTURAL PROTEIN; VIRUS PROTEIN; ZIDOVUDINE;

ANTIVIRAL ACTIVITY; GENE MAPPING; GENE STRUCTURE; HEPATITIS C; HEPATITIS C VIRUS; PRIORITY JOURNAL; PROTEIN PROCESSING; REVIEW; RNA TRANSLATION; VIRAL GENETICS; VIRION;

ANIMALS; ANTIVIRAL AGENTS; GENOME, VIRAL; HEPACIVIRUS; HUMANS; PROTEIN BIOSYNTHESIS; PROTEIN PROCESSING, POST-TRANSLATIONAL; VIRAL PROTEINS; VIRION; VIRUS REPLICATION;

EID: 0031906287     PISSN: 02580330     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000060472     Document Type: Article

References (235)

1. Alter HJ, Holland PV, Morrow AG, Purcell RH, Feinstone SM, Moritsugu Y: Clinical and serological analysis of transfusion-associated hepatitis. Lancet 1975;ii:838-841.
2. Feinstone SM, Kapikian AZ, Purcell RH, Alter HJ, Holland PV: Transfusion-associated hepatitis not due to viral hepatitis type A or B. N Engl J Med 1975;292:767-770.
3. Prince AM, Brotman B, Grady GF, Kuhns WJ, Hazzi C, Levine RW, Millian SJ: Long-incubation post-transfusion hepatitis without serological evidence of exposure to hepatitis B virus. Lancet 1974; ii:241-246.
4. Knodell RG, Conrad ME, Dienstag JL, Bell CJ: Etiological spectrum of post-transfusion hepatitis. Gastroenterology 1975;69:1278-1285.
5. Alter HJ, Purcell RH, Holland PV, Popper H: Transmissible agent in non-A, non-B hepatitis. Lancet 1978;i:459-463.
6. Hollinger FB, Gitnick G, Aach RD, Szmuness W, Mosley JW, Stevens CE, Peters RL, Weiner JM, Werch JB, Lander JJ: Non-A, non-B hepatitis transmission in chimpanzees: A project of the transfusion-transmitted viruses study group. Intervirology 1978;10:60-68.
7. Tabor E, Garety RJ, Drucker JA, Seeff LB, Hoofnagle JF, Jackson DR, April M, Barker LF, Pineda-Tamondong G: Transmission of non-A, non-B hepatitis from man to chimpanzee. Lancet 1978;i:463-466.
8. He LF, Alling D, Popkin T, Shapiro M, Alter HJ, Purcell RH: Determining the size of non-A, non-B hepatitis by filtration. J Infect Dis 1987;156:636-640.
9. Bradley DW, Maynard JE, Popper H, Cook EH, Ebert JW, McCaustland KA, Schable CA, Fields HA: Posttransfusion non-A, non-B hepatitis: Physicochemical properties of two distinct agents. J Infect Dis 1983;148:254-265.
10. Feinstone SM, Mihalik KB, Kamimura T, Alter HJ, London WT, Purcell RH: Inactivation of hepatitis B virus and non-A, non-B hepatitis by chloroform. Infect Immun 1983;41:816-821.
11. Choo Q-L, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M: Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989;244:359-362.
12. Bradley D, McCaustland K, Krawczynski K, Spelbring J, Humphrey C, Cook EH: Hepatitis C virus: Buoyant density of the factor VIII-derived isolate in sucrose. J Med Virol 1991;34:206-208.
13. Carrick RJ, Schlauder GG, Peterson DA, Mushahwar IK: Examination of the buoyant density of hepatitis C virus by the polymerase chain reaction. J Virol Methods 1992;39:279-289.
14. Choo S-H, So H-S, Cho JM, Ryu W-S: Association of hepatitis C virus particles with immunoglobulin: A mechanism for persistent infection. J Gen Virol 1995;76:2337-2341.
15. Hijikata M, Shimizu YK, Kato H, Iwamoto A, Shih JW, Alter HJ, Purcell RH, Yoshikura H: Equilibrium centrifugation studies of hepatitis C virus: Evidence for circulating immune complexes. J Virol 1993;67:1953-1958.
16. Kaito M, Watanabe S, Tsukiyama-Kohara K, Yamaguchi K, Kobayashi Y, Konishi M, Yokoi M, Ishida S, Suzuki S, Kohara M: Hepatitis C virus particle detected by immunoelectron microscopic study. J Gen Virol 1994;75:1755-1760.
17. Kanto T, Hayashi N, Takehara T, Hagiwara H, Mita E, Naito M, Kasahara A, Fusamoto H, Kamada T: Buoyant density of hepatitis C virus recovered from infected hosts: Two different features in sucrose equilibrium density-gradient centrifugation related to degree of liver inflammation. Hepatology 1994;19:296-302.
18. Kanto T, Hayashi N, Takehara T, Hagiwara H, Mita E, Naito M, Kasahara A, Fusamoto H, Kamada T: Density analysis of hepatitis C virus particle population in the circulation of infected hosts: Implications for virus neutralization or persistence. J Hepatol 1995;22:440-448.
19. Li X, Jeffers LJ, Shao L, Reddy KR, de Medina M, Scheffel J, Moore B, Schiff ER: Identification of hepatitis C virus by immunoelectron microscopy. J Viral Hepatitis 1995;2:227-234.
20. Miyamoto H, Okamoto H, Sato K, Tanaka T, Mishiro S: Extraordinarily low density of hepatitis C virus estimated by sucrose density centrifugation and polymerase chain reaction. J Gen Virol 1992;73:715-718.
21. Prince AM, Huima-Byron T, Parker TS, Levine DM: Visualization of hepatitis C virions and putative defective interfering particles isolated from low-density lipoproteins. J Viral Hepatitis 1996;3:11-17.
22. Thomssen R, Bonk S, Propfe C, Heermann KH, Köchel HG, Uy A: Association of hepatitis C virus in human sera with beta-lipoprotein. Med Microbiol Immunol 1992;181:293-300.
23. Thomssen R, Bonk S, Thiele A: Density heterogeneities of hepatitis C virus in human sera due to the binding of beta-lipoproteins and immunoglobulins. Med Microbiol Immunol 1993;182:329-334.
24. Sato K, Okamoto H, Aihara S, Hoshi Y, Tanaka T, Mishiro S: Demonstration of sugar moiety on the surface of hepatitis C virions recovered from the circulation of infected humans. Virology 1993; 196:354-357.
25. Shimizu YK, Feinstone SM, Kohara M, Purcell RH, Yoshikura H: Hepatitis C virus: Detection of intracellular virus particles by electron microscopy. Hepatology 1996;23:205-209.
26. Takahashi K, Kishimoto S, Yoshizawa H, Okamoto H, Yoshikawa A, Mishiro S: p26 protein and 33-nm particle associated with nucleocapsid of hepatitis C virus recovered from the circulation of infected hosts. Virology 1992;191:431-434.
27. Mizuno M, Yamada G, Tanaka T, Shimotohno K, Takatani M, Tsuji T: Virion-like structures in Hela G cells transfected with the full-length sequence of the hepatitis C virus genome. Gastroenterology 1995;109:1933-1940.
28. Bartenschlager R, Ahlborn-Laake L, Mous J, Jacobsen H: Nonstructural protein 3 of the hepatitis C virus encodes a serine-type proteinase required for cleavage at the NS3/4 and NS4/5 junctions. J Virol 1993;67:3835-3844.
29. Eckart MR, Selby M, Masiarz F, Lee C, Berger K, Crawford K, Kuo C, Kuo G, Houghton M, Choo Q-L: The hepatitis C virus encodes a serine protease involved in processing of the putative nonstructural proteins from the viral polyprotein precursor. Biochem Biophys Res Commun 1993; 192:399-406.
30. Grakoui A, McCourt DW, Wychowski C, Feinstone SM, Rice CM: Characterization of the hepatitis C virus-encoded serine proteinase: Determination of proteinase-dependent polyprotein cleavage sites. J Virol 1993;67:2832-2843.
31. Grakoui A, McCourt DW, Wychowski C, Feinstone SM, Rice CM: A second hepatitis C virus-encoded proteinase. Proc Natl Acad Sci USA 1993;90:10583-10587.
32. Hijikata M, Kato N, Ootsuyama Y, Nakagawa M, Shimotohno K: Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis. Proc Natl Acad Sci USA 1991;88:5547-5551.
33. Hijikata M, Mizushima H, Akagi T, Mori S, Kakiuchi N, Kato N, Tanaka T, Kimura K, Shimotohno K: Two distinct proteinase activities required for the processing of a putative nonstructural precursor protein of hepatitis C virus. J Virol 1993;67:4665-4675.
34. Lin C, Lindenbach BD, Prágai B, McCourt DW, Rice CM: Processing of the hepatitis C virus E2-NS2 region: Identification of p7 and two distinct E2-specific products with different C termini. J Virol 1994;68:5063-5073.
35. Manabe S, Fuke I, Tanishita O, Kaji C, Gomi Y, Yoshida S, Mori C, Takamizawa A, Yoshida I, Okayama H: Production of nonstructural proteins of hepatitis C virus requires a putative viral protease encoded by NS3. Virology 1994;198:636-644.
36. Mizushima H, Hijikata M, Tanji Y, Kimura K, Shimotohno K: Analysis of N-terminal processing of hepatitis C virus nonstructural protein 2. J Virol 1994;68:2731-2734.
37. Mizushima H, Hijikata H, Asabe S-I, Hirota M, Kimura K, Shimotohno K: Two hepatitis C virus glycoprotein E2 products with different C termini. J Virol 1994;68:6215-6222.
38. Selby MJ, Glazer E, Masiarz F, Houghton M: Complex processing and protein:protein interactions in the E2:NS2 region of HCV. Virology 1994;204:114-122.
39. Tomei L, Failla C, Santolini E, De Francesco R, La Monica N: NS3 is a serine protease required for processing of hepatitis C virus polyprotein. J Virol 1993;67:4017-4026.
40. Francki RIB, Fauquet CM, Knudson DL, Brown F: Classification and nomenclature of viruses: Fifth report of the international committee on taxonomy of viruses. Arch Virol 1991;(suppl 2):223.
41. Linnen J, Wages J, Zhangkeck ZY, Fry KE, Krawczynski KZ, Alter H, Koonin E, Gallagher M, Alter M, Hadziyannis S, Karayiannis P, Fung K, Nakatsuji Y, Shih J, Young L, Piatak M, Hoover C, Fernandez J, Chen S, Zou JC, Morris T, Hyams KC, Ismay S, Lifson JD, Hess G, Kim JP: Molecular cloning and disease association of hepatitis G virus: A transfusion-transmissible agent. Science 1996;271:505-508.
42. Simons JN, Pilotmatias TJ, Leary TP, Dawson GJ, Desai SM, Schlauder GG, Muerhoff AS, Erker JC, Buijk SL, Chalmers ML, Vansant CL, Mushahwar IK: Identification of two flavivirus-like genomes in the GB hepatitis agent. Proc Natl Acad Sci USA 1995;92:3401-3405.
43. Simons JN, Leary TP, Dawson GJ, Pilotmatias TJ, Muerhoff AS, Schlauder GG, Desai SM, Mushahwar IK: Isolation of novel virus-like sequences associated with human hepatitis. Nature Med 1995;1:564-569.
44. Muerhoff AS, Leary TP, Simons JN, Pilotmatias TJ, Dawson GJ, Erker JC, Chalmers ML, Schlauder GG, Desai SM, Mushahwar IK: Genomic organization of GB viruses A and B: Two new members of the Flaviviridae associated with GB agent hepatitis. J Virol 1995;69:5621-5630.
45. Miller RH, Purcell RH: Hepatitis C virus shares amino acid sequence similarity with pestiviruses and flaviviruses as well as members of two plant virus supergroups. Proc Natl Acad Sci USA 1990; 87:2057-2061.
46. Brown EA, Zhang H, Ping L-H, Lemon SM: Secondary structure of the 5′ nontranslated regions of hepatitis C virus and pestivirus genomic RNAs. Nucleic Acids Res 1992;20:5041-5045.
47. Honda M, Brown EA, Lemon SM: Stability of a stem-loop involving the initiator AUG controls the efficiency of internal initiation of translation on hepatitis C virus RNA. RNA 1996;2:955-968.
48. Smith DB, Mellor J, Jarvis LM, Davidson F, Kolberg J, Urdea M, Yap P, Group TIHCS: Variation of the hepatitis C virus 5′ non-coding region: Implications for secondary structure, virus detection and typing. J Gen Virol 1995;76:1749-1761.
49. Wang C, Le S-Y, Ali N, Siddiqui A: An RNA pseudoknot is an essential structural element of the internal ribosome entry site located within the hepatitis C virus 5′ noncoding region. RNA 1995; 1:526-537.
50. Fukushi S, Katayama K, Kurihara C, Ishiyama N, Hoshino FB, Ando T, Oya A: Complete 5′ noncoding region is necessary for the efficient internal initiation of hepatitis C virus RNA. Biochem Biophys Res Commun 1994;199:425-432.
51. Honda M, Ping L-H, Rijnbrand RCA, Amphlett E, Clarke B, Rowlands D, Lemon SM: Structural requirements for initiation of translation by internal ribosome entry within genome-length hepatitis C virus RNA. Virology 1996;222:31-42.
52. Reynolds JE, Kaminski A, Kettinen HJ, Grace K, Clarke BE, Carroll AR, Rowlands DJ, Jackson RJ: Unique features of internal initiation of hepatitis C virus RNA translation. EMBO J 1995;14: 6010-6020.
53. Rijnbrand R, Bredenbeek P, van der Straaten T, Whetter L, Inchauspé G, Lemon S, Spaan W: Almost the entire 5′ non-translated region of hepatitis C virus is required for cap-independent translation. FEBS Lett 1995;365:115-119.
54. Tsukiyama-Kohara K, Iizuka N, Kohara M, Nomoto A: Internal ribosome entry site within hepatitis C virus RNA. J Virol 1992;66:1476-1483.
55. Wang C, Sarnow P, Siddiqui A: Translation of human hepatitis C virus RNA in cultured cells is mediated by an internal ribosome-binding mechanism. J Virol 1993;67:3338-3344.
56. Lu HH, Wimmer E: Poliovirus chimeras replicating under the translational control of genetic elements of hepatitis C virus reveal unusual properties of the internal ribosomal entry site of hepatitis C virus. Proc Natl Acad Sci USA 1996;93:1412-1417.
57. Iizuka N, Najita L, Franzusoff A, Sarnow P: Cap-dependent and cap-independent translation by internal initiation of mRNAs in cell extracts prepared from Saccharomyces cerevisiae. Mol Cell Biol 1994;14:7322-7330.
58. Reynolds JE, Kaminski A, Carroll AR, Clarke BE, Rowlands DJ, Jackson RJ: Internal initiation of translation of hepatitis C virus RNA: The ribosome entry site is at the authentic initiation codon. RNA 1996;2:867-878.
59. Yoo BJ, Spaete RR, Geballe AP, Selby M, Houghton M, Han JH: 5′ end-dependent translation initiation of hepatitis C viral RNA and the presence of putative positive and negative translational control elements within the 5′ untranslated region. Virology 1992;191:889-899.
60. Rijnbrand R, Abbink TEM, Haasnoot PCJ, Spaan WJM, Bredenbeek PJ: The influence of AUG codons in the hepatitis C virus 5′ nontranslated region on translation and mapping of the translation initiation window. Virology 1996;226:47-56.
61. Belsham GJ: RNA-protein interactions in regulation of picornavirus RNA translation. Microbiol Rev 1996;60:499-511.
62. Kaminski A, Hunt SL, Patton JG, Jackson RJ: Direct evidence that polypyrimidine tract binding protein (PTB) is essential for internal initiation of translation of encephalomyocarditis virus RNA. RNA 1995;1:924-938.
63. Ali N, Siddiqui A: Interaction of polypyrimidine tract-binding protein with the 5′ noncoding region of the hepatitis C virus RNA genome and its functional requirement in internal initiation of translation. J Virol 1995;69:6367-6375.
64. Wang S, Sarnow P, Siddiqui A: A conserved helical element is essential for internal initiation of translation of hepatitis C virus RNA. J Virol 1994;68:7301-7307.
65. Fukushi S, Kurihara C, Ishiyama N, Hoshino FB, Oya A, Katayama K: The sequence element of the internal ribosome entry site and a 25-kilodalton cellular protein contribute to efficient internal initiation of translation of hepatitis C virus RNA. J Virol 1997;71:1662-1666.
66. Yen J-H, Chang SC, Hu C-R, Chu S-C, Lin S-S, Hsieh Y-S, Chang M-F: Cellular proteins specifically bind to the 5′-noncoding region of hepatitis C virus RNA. Virology 1995;208:723-732.
67. Hüssy P, Langen H, Mous J, Jacobsen H: Hepatitis C virus core protein: Carboxy-terminal boundaries of two processed species suggest cleavage by a signal peptide peptidase. Virology 1996;224: 93-104.
68. Santolini E, Migliaccio G, La Monica N: Biosynthesis and biochemical properties of the hepatitis C virus core protein. J Virol 1994;68:3631-3641.
69. Santolini E, Pacini L, Fipaldini C, Migliaccio G, La Monica N: The NS2 protein of hepatitis C virus is a transmembrane polypeptide. J Virol 1995;69:7461-7471.
70. Lyko F, Martoglio B, Jungnickel B, Rapoport TA, Dobberstein B, Martoglio B, Hofmann MW, Brunner J, Dobberstein B: Signal sequence processing in rough microsomes. The protein-conducting channel in the membrane of the endoplasmic reticulum is open laterally toward the lipid bilayer. J Biol Chem 1995;270:19873-19878.
71. Bazan JF, Fletterick RJ: Detection of a trypsin-like serine protease domain in flaviviruses and pestiviruses. Virology 1989;171:637-639.
72. Bazan JF, Fletterick RJ: Structural and catalytic models of trypsin-like viral proteases. Semin Virol 1990;1:311-322.
73. Chambers TJ, Hahn CS, Galler R, Rice CM: Flavivirus genome organization, expression, and replication. Annu Rev Microbiol 1990;44:649-688.
74. Gorbalenya AE, Donchenko AP, Koonin EV, Blinov VM: N-terminal domains of putative helicases of flavi- and pestiviruses may be serine proteases. Nucleic Acids Res 1989;17:3889-3897.
75. Bartenschlager R, Ahlborn-Laake L, Mous J, Jacobsen H: Kinetic and structural analyses of hepatitis C virus polyprotein processing. J Virol 1994;68:5045-5055.
76. Lin C, Prágai B, Grakoui A, Xu J, Rice CM: The hepatitis C virus NS3 serine proteinase: Trans processing requirements and cleavage kinetics. J Virol 1994;68:8147-8157.
77. Tanji Y, Hijikata M, Hirowatari Y, Shimotohno K: Identification of the domain required for transcleavage activity of hepatitis C viral serine proteinase. Gene 1994;145:215-219.
78. Tanji Y, Hijikata M, Hirowatari Y, Shimotohno K: Hepatitis C virus polyprotein processing: Kinetics and mutagenic analysis of serine proteinase-dependent cleavage. J Virol 1994;68:8418-8422.
79. Failla C, Tomei L, De Francesco R: Both NS3 and NS4A are required for proteolytic processing of hepatitis C virus nonstructural proteins. J Virol 1994;68:3753-3760.
80. Tanji Y, Hijikata M, Satoh S, Kaneko T, Shimotohno K: Hepatitis C virus-encoded nonstructural protein NS4A has versatile functions in viral protein processing. J Virol 1995;69:1575-1581.
81. Lin C, Rice CM: The hepatitis C virus NS3 serine proteinase and NS4A cofactor: Establishment of a cell-free trans-processing assay. Proc Natl Acad Sci USA 1995;92:7622-7626.
82. Steinkühler C, Tomei L, De Francesco R: In vitro activity of hepatitis C virus protease NS3 purified from recombinant baculovirus-infected Sf9 cells. J Biol Chem 1996;271:6367-6373.
83. Steinkühler C, Urbani A, Tomei L, Biasiol G, Sardana M, Bianchi E, Pessi A, De Francesco R: Activity of purified hepatitis C virus protease NS3 on peptide substrates. J Virol 1996;70:6694-6700.
84. Bartenschlager R, Lohmann V, Wilkinson T, Koch JO: Complex formation between the NS3 serine-type proteinase of the hepatitis C virus and NS4A and its importance for polyprotein maturation. J Virol 1995;69:7519-7528.
85. Failla C, Tomei L, De Francesco R: An amino-terminal domain of the hepatitis C virus NS3 protease is essential for interaction with NS4A. J Virol 1995;69:1769-1777.
86. Lin C, Thomson JA, Rice CM: A central region in the hepatitis C virus NS4A protein allows formation of an active NS3-NS4A serine proteinase complex in vivo and in vitro. J Virol 1995;69: 4373-4380.
87. Satoh S, Tanji Y, Hijikata M, Kimura K, Shimotohno K: The N-terminal region of hepatitis C virus nonstructural protein 3 (NS3) is essential for stable complex formation with NS4A. J Virol 1995;69:4255-4260.
88. Shimizu Y, Yamaji K, Masuho Y, Yokota T, Inoue H, Sudo K, Satoh S, Shimotohno K: Identification of the sequence on NS4A required for enhanced cleavage of the NS5A/5B site by hepatitis C virus NS3 protease. J Virol 1996;70:127-132.
89. Tomei L, Failla C, Vitale RL, Bianchi E, De Francesco R: A central hydrophobic domain of the hepatitis C virus NS4A protein is necessary and sufficient for the activation of the NS3 protease. J Gen Virol 1996;77:1065-1070.
90. Hijikata M, Mizushima H, Tanji Y, Komoda Y, Hirowatari Y, Akagi T, Kato N, Kimura K, Shimotohno K: Proteolytic processing and membrane association of putative nonstructural proteins of hepatitis C virus. Proc Natl Acad Sci USA 1993;90:10773-10777.
91. Pizzi E, Tramontano A, Tomei L, La Monica N, Failla C, Sardana M, Wood T, De Francesco R: Molecular-model of the specificity pocket of the hepatitis C virus protease: Implications for substrate recognition. Proc Natl Acad Sci USA 1994;91:888-892.
92. Bartenschlager R, Ahlborn-Laake L, Yasargil K, Mous J, Jacobsen H: Substrate determinants for cleavage in cis and in trans by the hepatitis C virus NS3 proteinase. J Virol 1995;69:198-205.
93. Kolykhalov AA, Agapov EV, Rice CM: Specificity of the hepatitis C virus serine proteinase: Effects of substitutions at the 3/4A, 4A/4B, 4B/5A, and 5A/5B cleavage sites on polyprotein processing. J Virol 1994;68:7525-7533.
94. Leinbach SS, Bhat RA, Xia S-M, Hum W-T, Stauffer B, Davis AR, Hung PP, Mizutani S: Substrate specificity of the NS3 serine proteinase of hepatitis C virus as determined by mutagenesis at the NS3/NS4A junction. Virology 1994;204:163-169.
95. Kim JL, Morgenstern KA, Lin C, Fox T, Dwyer MD, Landro JA, Chambers SP, Markland W, Lepre CA, O'Malley ET, Harbeson SL, Rice CM, Murcko MA, Caron PR, Thomson JA: Crystal structure of the hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide. Cell 1996;87:343-355.
96. Love RA, Parge H, Wickersham JA, Hostomsky Z, Habuka N, Moomaw EW, Adachi T, Hostomska Z: The crystal structure of hepatitis C virus NS3 proteinase reveals a trypsin-like fold and a structural zinc binding site. Cell 1996;87:331-342.
97. De Francesco R, Urbani A, Nardi MC, Tomei L, Steinkuhler C, Tramontano A: A zinc binding site in viral serine proteinases. Biochemistry 1996;35:13282-13287.
98. Hirowatari Y, Hijikata M, Tanji Y, Nyunoya H, Mizushima H, Kimura K, Tanaka T, Kato N, Shimotohno K: Two proteinase activities in HCV polypeptide expressed in insect cells using baculovirus vector. Arch Virol 1993;133:349-356.
99. Overton H, Mcmillan D, Gillespie F, Mills J: Recombinant baculovirus-expressed NS3 proteinase of hepatitis C virus shows activity in cell-based and in vitro assays. J Gen Virol 1995;76:3009-3019.
100. Suzuki T, Sato M, Chieda S, Shoji I, Harada T, Yamakawa Y, Watabe S, Matsuura Y, Miyamura T: In vivo and in vitro trans-cleavage activity of hepatitis C virus serine proteinase expressed by recombinant baculoviruses. J Gen Virol 1995;76:3021-3029.
101. Bianchi E, Steinkühler C, Taliani M, Urbani A, De Francesco R, Pessi A: Synthetic depsipeptide substrates for the assay of human hepatitis C virus protease. Anal Biochem 1996;237:239-244.
102. Butkiewicz NJ, Wendel M, Zhang RM, Jubin R, Pichardo J, Smith EB, Hart AM, Ingram R, Durkin J, Mui PW, Murray RG, Ramanathan L, Dasmahapatra B: Enhancement of hepatitis C virus NS3 proteinase activity by association with NS4A-specific synthetic peptides: Identification of sequence and critical residues of NS4A for the cofactor activity. Virology 1996;225:328-338.
103. D'Souza EDA, Grace K, Sangar DV, Rowlands DJ, Clarke BE: In vitro cleavage of hepatitis C virus polyprotein substrates by purified recombinant NS3 protease. J Gen Virol 1995;76:1729-1736.
104. Komoda Y, Hijikata M, Tanji Y, Hirowatari Y, Mizushima H, Kimura K, Shimotohno K: Processing of hepatitis C viral polyprotein in Escherichia coli. Gene 1994;145:221-226.
105. Shoji I, Suzuki T, Chieda S, Sato M, Harada T, Chiba T, Matsuura Y, Miyamura T: Proteolytic activity of NS3 serine proteinase of hepatitis C virus efficiently expressed in Escherichia coli. Hepatology 1995;22:1648-1655.
106. Hahm B, Han DS, Back SH, Song O-K, Cho M-J, Kim C-J, Shimotohno K, Jang SK: NS3-4A of hepatitis C virus is a chymotrypsin-like protease. J Virol 1995;69:2534-2539.
107. Han DS, Hahm B, Rho H-M, Jang SK: Identification of the protease domain in NS3 of hepatitis virus. J Gen Virol 1995;76:985-993.
108. Bouffard P, Bartenschlager R, Ahlborn-Laake L, Mous J, Roberts N, Jacobsen H: An in vitro assay for hepatitis C virus NS3 serine proteinase. Virology 1995;209:52-59.
109. Kakiuchi N, Hijikata M, Komoda Y, Tanji Y, Hirowatari Y, Shimotohno K: Bacterial expression and analysis of cleavage activity of HCV serine proteinase using recombinant and synthetic substrate. Biochem Biophys Res Commun 1995;210:1059-1065.
110. Sudo K, Inoue H, Shimizu Y, Yamaji K, Konno K, Shigeta S, Kaneko T, Yokota T, Shimotohno K: Establishment of an in vitro assay system for screening hepatitis C virus protease inhibitors using high performance liquid chromatography. Antiviral Res 1996;32:9-18.
111. Taliani M, Bianchi E, Narjes F, Fossatelli M, Urbani A, Steinkühler C, De Francesco R, Pessi A: A continuous assay of hepatitis C virus protease based on resonance energy transfer depsipcptide substrates. Anal Biochem 1996;240:60-67.
112. Komoda Y, Hijikata M, Sato S, Asabe S-I, Kimura K, Shimotohno K: Substrate requirements of hepatitis C virus proteinase for intermolecular polypeptide cleavage in Escherichia coli. J Virol 1994; 68:7351-7357.
113. Mori A, Yamada K, Kimura J, Koide T, Yuasa S, Yamada E, Miyamura T: Enzymatic characterization of purified NS3 serine proteinase of hepatitis C virus expressed in Escherichia coli. FEBS Lett 1996;378:37-42.
114. Filocamo G, Pacini L, Migliaccio G: Chimeric Sindbis virus dependent upon the NS3 protease of hepatitis C virus. J Virol 1997;71:1417-1427.
115. Hahm B, Back SH, Lee TG, Wimmer E, Jang SK: Generation of a novel poliovirus with a requirement of hepatitis C virus protease activity. Virology 1996;226:318-326.
116. Hirowatari Y, Hijikata M, Shimotohno K: A novel method for analysis of viral proteinase activity encoded by hepatitis C virus in cultured cells. Anal Biochem 1995;225:113-120.
117. Song O-K, Cho OH, Hahm B, Jang SK: Development of an in vivo assay system suitable for screening inhibitors of hepatitis C viral protease. Mol Cells 1996;6:183-189.
118. Chu M, Mierzwa R, Truumees I, King A, Patel M, Berrie R, Hart A, Butkiewicz N, Dasmahapatra B, Chan TM, Puar MS: Structure of Sch 68631: A new hepatitis C virus proteinase inhibitor from Streptomyces sp. Tetrahedron Lett 1996;37:7229-7232.
119. Jiang W, Bond JS: Families of metalloendopeptidases and their relationships. FEBS Lett 1992;312: 110-114.
120. Gorbalenya AE, Snijder EJ: Viral cysteine proteinases. Perspect Drug Discovery Design 1996;6: 64-86.
121. Reed KE, Grakoui A, Rice CM: Hepatitis C virus encoded NS2-3: Cleavage site mutagenesis and requirements for bimolecular cleavage. J Virol 1995;69:4127-4136.
122. D'Souza ED, O'Sullivan E, Amphlett EM, Rowlands DJ, Sangar DV, Clarke BE: Analysis of NS3-mediated processing of the hepatitis C virus non-structural region in vitro. J Gen Virol 1994;75: 3469-3476.
123. Grakoui A, Wychowski C, Lin C, Feinstone SM, Rice CM: Expression and identification of hepatitis C virus polyprotein cleavage products. J Virol 1993;67:1385-1395.
124. Harada S, Watanabe Y, Takeuchi K, Suzuki T, Katayama T, Takebe Y, Saito I, Miyamura T: Expression of processed core protein of hepatitis C virus in mammalian cells. J Virol 1991;65: 3015-3021.
125. Moradpour D, Englert C, Wakita T, Wands JR: Characterization of cell lines allowing tightly regulated expression of hepatitis C virus core protein. Virology 1996;222:51-63.
126. Ravaggi A, Natoli G, Primi D, Albertini A, Levrero M, Cariani E: Intracellular localization of full-length and truncated hepatitis C virus core protein expressed in mammalian cells. J Hepatol 1994; 20:833-836.
127. Suzuki R, Matsuura Y, Susuki T, Ando A, Chiba J, Harada S, Saito I, Miyamura T: Nuclear localization of the truncated hepatitis C virus core protein with its hydrophobic C terminus deleted. J Gen Virol 1995;76:53-61.
128. Lo S-Y, Masiarz F, Hwang SB, Lai MMC, Ou J-H: Differential subcellular localization of hepatitis C virus core gene products. Virology 1995;213:455-461.
129. Chang SC, Yen J-H, Kang H-Y, Jang M-H, Chang M-F: Nuclear localization signals in the core protein of hepatitis C virus. Biochem Biophys Res Commun 1994;205:1284-1290.
130. Kim DW, Suzuki R, Harada T, Saito I, Miyamura T: Trans-suppression of gene expression by hepatitis C viral core protein. Jpn J Med Sci Biol 1994;47:211-220.
131. Lanford RE, Notvall L, Chavez D, White R, Frenzel G, Simonsen C, Kim J: Analysis of hepatitis C virus capsid, E1, and E2/NS1 proteins expressed in insect cells. Virology 1993;197:225-235.
132. Lo S-Y, Selby M, Tong M, Ou J-H: Comparative studies of the core gene products of two different hepatitis C virus isolates: Two alternative forms determined by a single amino acid substitution. Virology 1994;199:124-131.
133. Shih C-M, Lo SJ, Miyamura T, Chen S-Y, Lee Y-HW: Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cells. J Virol 1993;67:5823-5832.
134. Shih C-M, Chen C-M, Chen S-Y, Lee Y-HW: Modulation of the trans-suppression activity of hepatitis C virus core protein by phosphorylation. J Virol 1995;69:1160-1171.
135. Ray RB, Lagging LM, Meyer K, Ray R: Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype. J Virol 1996;70:4438-4443.
136. Ray RB, Meyer K, Ray R: Suppression of apoptotic cell death by hepatitis C virus core protein. Virology 1996;226:176-182.
137. Rüster B, Zeuzem S, Roth WK: Hepatitis C virus sequences encoding truncated core proteins detected in a hepatocellular carcinoma. Biochem Biophys Res Commun 1996;219:911-915.
138. Ray RB, Lagging LM, Meyer K, Steele R, Ray R: Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core protein. Virus Res 1995;37:209-220.
139. Hwang SB, Lo S-Y, Ou J-H, Lai MMC: Detection of cellular proteins and viral core protein interacting with the 5′ untranslated region of hepatitis C virus RNA. J Biomed Sci 1995;2:227-236.
140. Matsumoto M, Hwang SB, Jeng K-S, Zhu N, Lai M MC: Homotypic interaction and multimerization of hepatitis C virus core protein. Virology 1996;218:43-51.
141. Lo S-Y, Selby MJ, Ou J-H: Interaction between hepatitis C virus core protein and E1 envelope protein. J Virol 1996;70:5177-5182.
142. Matsumoto M, Hsieh T-Y, Zhu N, VanArsdale T, Hwang SB, Jeng K-S, Gorbalenya AE, Lo S-Y, Ou J-H, Ware CF, Lai MMC: Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-β receptor. J Virol 1997;71:1301-1309.
143. Hsu HH, Donets M, Greenberg HB, Feinstone SM: Characterization of hepatitis C virus structural proteins with a recombinant baculovirus expression system. Hepatology 1993;17:763-771.
144. Kohara M, Tsukiyama-Kohara K, Maki N, Asano K, Yamaguchi K, Miki K, Tanaka S, Hattori N, Matsuura Y, Saito I, Miyamura T, Nomoto A: Expression and characterization of glycoprotein gp35 of hepatitis C virus using recombinant vaccinia virus. J Gen Virol 1992;73:2313-2318.
145. Koike K, Moriya K, Ishibashi K, Matsuura Y, Suzuki T, Saito I, Iino S, Kurokawa K, Miyamura T: Expression of hepatitis C virus envelope proteins in transgenic mice. J Gen Virol 1995;76: 3031-3038.
146. Matsuura Y, Harada S, Suzuki R, Watanabe Y, Inoue Y, Saito I, Miyamura T: Expression of processed envelope protein of hepatitis C virus in mammalian and insect cells. J Virol 1992;66: 1425-1431.
147. Matsuura Y, Suzuki T, Suzuki R, Sato M, Aizaki H, Saito I, Miyamura T: Processing of E1 and E2 glycoproteins of hepatitis C virus expressed in mammalian and insect cells. Virology 1994;205: 141-150.
148. Ryu W-S, Choi D-Y, Yang J-Y, Kim C-H, Kwon Y-S, So H-S, Cho JM: Characterization of the putative E2 envelope glycoprotein of hepatitis C virus expressed in stably transformed Chinese hamster ovary cells. Mol Cells 1995;5:563-568.
149. Spaete RR, Alexander D, Rugroden ME, Choo Q-L, Berger K, Crawford K, Kuo C, Leng S, Lee C, Ralston R, Thudium K, Tung JW, Kuo G, Houghton M: Characterization of the hepatitis E2/ NS1 gene product expressed in mammalian cells. Virology 1992;188:819-830.
150. Ralston R, Thudium K, Berger K, Kuo C, Gervase B, Hall J, Selby M, Kuo G, Houghton M, Choo Q-L: Characterization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia viruses. J Virol 1993;67:6753-6761.
151. Dubuisson J, Hsu HH, Cheung RC, Greenberg H, Russell DR, Rice CM: Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses. J Virol 1994;68:6147-6160.
152. Hussy P, Schmid G, Mous J, Jacobsen H: Purification and in vitro-phospholabeling of secretory envelope proteins E1 and E2 of hepatitis C virus expressed in insect cells. Virus Res 1996;45:45-57.
153. Dubuisson J, Rice CM: Hepatitis C virus glycoprotein folding: Disulfide bond formation and association with calnexin. J Virol 1996;70:778-786.
154. Hijikata M, Kato N, Ootsuyama Y, Nakagawa M, Ohkoshi S, Shimotohno K: Hypervariable regions in the putative glycoprotein of hepatitis C virus. Biochem Biophys Res Commun 1991;175:220-228.
155. Weiner AJ, Brauer MJ, Rosenblatt J, Richman KH, Tung J, Crawford K, Bonino F, Saracco G, Choo Q-L, Houghton M, Han JH: Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins. Virology 1991;180:842-848.
156. Higashi Y, Kakumu S, Yoshioka K, Wakita T, Mizokami M, Ohba K, Ito Y, Ishikawa T, Takayanagi M, Nagai Y: Dynamics of genome change in the E2/NS1 region of hepatitis C virus in vivo. Virology 1993;197:659-668.
157. Kato N, Ootsuyama Y, Ohkoshi S, Nakazawa T, Sekiya H, Hijikata M, Shimotohno K: Characterization of hypervariable regions in the putative envelope protein of hepatitis C virus. Biochem Biophys Res Commun 1992;189:119-127.
158. Kato N, Ootsuyama Y, Sekiya H, Ohkoshi S, Nakazawa T, Hijikata M, Shimotohno K: Genetic drift in hypervariable region 1 of the viral genome in persistent hepatitis C virus infection. J Virol 1994;68:4776-4784.
159. Kurosaki M, Enomoto N, Marumo F, Sato C: Rapid sequence variation of the hypervariable region of hepatitis C virus during the course of chronic infection. Hepatology 1993;18:1293-1299.
160. Kurosaki M, Enomoto N, Marumo F, Sato C: Evolution and selection of hepatitis C virus variants in patients with chronic hepatitis C. Virology 1994;205:161-169.
161. Ogata N, Alter HJ, Miller RH, Purcell RH: Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. Proc Natl Acad Sci USA 1991;88:3392-3396.
162. Okamoto H, Kojima M, Okada S-I, Yoshizawa H, Iizuka H, Tanaka T, Muchmore EE, Peterson DA, Ito Y, Mishiro S: Genetic drift of hepatitis C virus during an 8.2 year infection in a chimpanzee: Variability and stability. Virology 1992;190:894-899.
163. Kato N, Sekiya H, Ootsuyama Y, Nakazawa T, Hijikata M, Ohkoshi S, Shimotohno K: Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus. J Virol 1993;67:3923-3930.
164. Taniguchi S, Okamoto H, Sakamoto M, Kojima M, Tsuda F, Tanaka T, Munekata E, Muchmore EE, Peterson DA, Mishiro S: A structurally flexible and antigenically variable N-terminal domain of the hepatitis C virus E2/NS1 protein: Implication for an escape from antibody. Virology 1993; 195:297-301.
165. Weiner AJ, Geysen HM, Christopherson C, Hall JE, Mason TJ, Saracco G, Bonino F, Crawford K, Marion CD, Crawford KA, Brunetto M, Barr PJ, Miyamura T, McHutchinson J, Houghton M: Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: Potential role in chronic HCV infections. Proc Natl Acad Sci USA 1992;89:3468-3472.
166. Farci P, Alter HJ, Wong DC, Miller RH, Govindarajan S, Engle R, Shapiro M, Purcell RH: Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proc Natl Acad Sci USA 1994;91:7792-7796.
167. Shimizu YK, Hijikata M, Iwamoto A, Alter HJ, Purcell RH, Yoshikura H: Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. J Virol 1994; 68:1494-1500.
168. Zibert A, Schreier E, Roggendorf M: Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment. Virology 1995;208:653-661.
169. Choo Q-L, Kuo G, Ralston R, Weiner A, Chien D, Van Nest G, Han J, Berger K, Thudium K, Kuo C, Kansopon J, McFarland J, Tabrizi A, Ching K, Moss B, Cummins LB, Houghton M, Muchmore E: Vaccination of chimpanzees against infection by the hepatitis C virus. Proc Natl Acad Sci USA 1994;91:1294-1298.
170. Farci P, Alter HJ, Govindarajan S, Wong DC, Engle R, Lesniewski RR, Mushahwar IK, Desai SM, Miller RH, Ogata N, Purcell RH: Lack of protective immunity against reinfection with hepatitis C virus. Science 1992;258:135-140.
171. Prince A, Brotman B, Huima T, Pascual D, Jaffery M, Inchauspé G: Immunity in hepatitis C infection. J Infect Dis 1992;165:438-443.
172. Rosa D, Campagnoli S, Moretto C, Guenzi E, Cousens L, Chin M, Dong C, Weiner A, Lau JYN, Choo Q-L, Chien D, Pileri P, Houghton NJ, Abrignani S: A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: Cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells. Proc Natl Acad Sci USA 1996;93:1759-1763.
173. Elbers K, Tautz N, Becher P, Stoll D, Rumenapf T, Thiel H-J: Processing in the pestivirus E2-NS2 region: Identification of proteins p7 and E2p7. J Virol 1996;70:4131-4135.
174. Gwack T, Kim DW, Hang JH, Choe J: Characterization of RNA binding activity and RNA helicase activity of the hepatitis C virus NS3 protein. Biochem Biophys Res Commun 1996;225:654-659.
175. Hong Z, Ferrari E, Wright-Minogue J, Chase R, Risano C, Seelig G, Lee CG, Kwong AD: Enzymatic characterization of hepatitis C virus NS3/4A complexes expressed in mammalian cells by using the herpes simplex virus amplicon system. J Virol 1996;70:4261-4268.
176. Jin L, Peterson DL: Expression, isolation, and characterization of the hepatitis C virus ATPase/ RNA helicase. Arch Biochem Biophys 1995;323:47-53.
177. Kim DW, Gwack Y, Han JH, Choe J: C-terminal domain of the hepatitis C virus NS3 protein contains an RNA helicase activity. Biochem Biophys Res Commun 1995;215:160-166.
178. Preugschat F, Averett DR, Clarke BE, Porter DJT: A steady-state and pre-steady-state kinetic analysis of the NTPase activity associated with the hepatitis C virus NS3 helicase domain. J Biol Chem 1996;271:24449-24457.
179. Suzich JA, Tamura JK, Palmer-Hill F, Warrener P, Grakoui A, Rice CM, Feinstone SM, Collett MS: Hepatitis C virus NS3 protein polynucleotide-stimulated nucleoside triphosphatase and comparison with the related pestivirus and flavivirus enzymes. J Virol 1993;67:6152-6158.
180. Tai C-L, Chi W-K, Chen D-S, Hwang L-H: The helicase activity associated with hepatitis C virus nonstructural protein 3 (NS3). J Virol 1996;70:8477-8484.
181. Kanai A, Tanabe K, Kohara M: Poly(U) binding activity of hepatitis C virus NS3 protein, a putative RNA helicase. FEBS Lett 1995;376:221-224.
182. Warrener P, Collett MS: Pestivirus NS3 (p80) protein possesses RNA helicase activity. J Virol 1995; 69:1720-1726.
183. Eagles RM, Balmori-Melián E, Beck DL, Gardner RC, Forster RLS: Characterization of the NTPase, RNA-binding and RNA helicase activities of the cytoplasmic inclusion protein of tamarillo mosaic virus. Eur J Biochem 1994;224:677-684.
184. Lain S, Riechmann JL, Garcia JA: RNA helicase: A novel activity associated with a protein encoded by a positive strand RNA virus. Nucleic Acids Res 1991;18:7003-7006.
185. Borowski P, Heiland M, Oehlmann K, Becker B, Kornetzky L, Feucht H, Laufs R: Non-structural protein 3 of hepatitis C virus inhibits phosphorylation mediated by cAMP-dependent protein kinase. Eur J Biochem 1996;237:611-618.
186. Sakamuro D, Furukawa T, Takegami T: Hepatitis C virus nonstructural protein NS3 transforms NIH 3T3 cells. J Virol 1995;69:3893-3896.
187. Asabe S-I, Tanji Y, Satoh S, Kaneko T, Kimura K, Shimotohno K: The N-terminal region of hepatitis C virus-encoded NS5A is important for NS4A-dependent phosphorylation. J Virol 1997; 71:790-796.
188. Kaneko T, Tanji Y, Satoh S, Hijikata M, Asabe S, Kimura K, Shimotohno K: Production of two phosphoproteins from the NS5A region of the hepatitis C viral genome. Biochem Biophys Res Commun 1994;205:320-326.
189. Tanji Y, Kaneko T, Satoh S, Shimotohno K: Phosphorylation of hepatitis C virus-encoded nonstructural protein NS5A. J Virol 1995;69:3980-3986.
190. Kapoor M, Zhang L, Ramachandra M, Kusukawa J, Ebner KE, Padmanabhan R: Association between NS3 and NS5 proteins of dengue virus type 2 in the putative RNA replicase is linked to differential phosphorylation of NS5. J Biol Chem 1995;270:19100-19106.
191. Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, Izumi N, Marumo F, Sato C: Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. J Clin Invest 1995;96:224-230.
192. Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, Ogura Y, Izumi N, Marumo F, Sato C: Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. N Engl J Med 1996;334:77-81.
193. Behrens SE, Tomei L, De Francesco R: Identification and properties of the RNA-dependent RNA polymerase of hepatitis C virus. EMBO J 1996;15:12-22.
194. Hwang SB, Park K-J, Kim Y-S, Sung YC, Lai MMC: Hepatitis C virus NS5B protein is a membrane-associated phosphoprotein with a predominantly perinuclear localization. Virology 1997;227:439-446.
195. Han JH, Shyamala V, Richman KH, Brauer MJ, Irvine B, Urdea MS, Tekamp-Olson P, Kuo G, Choo Q-L, Houghton M: Characterization of the terminal regions of hepatitis C viral RNA: Indentification of conserved sequences in the 5′ untranslated region and poly(A) tails at the 3′ end. Proc Natl Acad Sci USA 1991;88:1711-1715.
196. Okamoto H, Kurai K, Okada S-I, Yamamoto K, Iizuka H, Tanaka T, Fukuda S, Tsuda F, Mishiro S: Full-length sequence of a hepatitis C virus genome having poor homology to reported isolates: Comparative study of four distinct genotypes. Virology 1992;188:331-341.
197. Okamoto H, Kojima M, Sakamoto M, Iizuka H, Hadiwandowo S, Suwignyo S, Miyakawa Y, Mayumi M: The entire nucleotide sequence and classification of a hepatitis C virus isolate of a novel genotype from an Indonesian patient with chronic liver disease. J Gen Virol 1994;75:629-635.
198. Tanaka T, Kato N, Nakagawa M, Ootsuyama Y, Cho M-J, Nakazawa T, Hijikata M, Ishimura Y, Shimotohno K: Molecular cloning of hepatitis C virus genome from a single Japanese carrier: Sequence variation within the same individual and among infected individuals. Virus Res 1992;23:39-53.
199. Wang Y, Okamoto H, Tsuda F, Nagayama R, Tao Q, Mishiro S: Prevalence, genotypes, and an isolate (HC-C2) of hepatitis C virus in Chinese patients with liver disease. J Med Virol 1993;40: 254-260.
200. Yamada N, Tanihara K, Mizokami M, Ohba K, Takada A, Tsutsumi M, Date T: Full-length sequence of the genome of hepatitis C virus type 3a: Comparative study with different genotypes. J Gen Virol 1994;75:3279-3284.
201. Hayashi N, Higashi H, Kaminaka K, Sugimoto H, Esumi M, Komatsu K, Hayashi K, Sugitani M, Suzuki K, Tadao O, Nozaki C, Mizuno K, Shikata T: Molecular cloning and heterogeneity of the human hepatitis C virus (HCV) genome. J Hepatol 1993;17(suppl 3):S94-S107.
202. Kato N, Hijikata M, Ootsuyama Y, Nakagawa M, Ohkoshi S, Sugimura T, Shimotohno K: Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc Natl Acad Sci USA 1990;87:9524-9528.
203. Okamoto H, Okada S, Sugiyama Y, Kurai K, Iizuka H, Machida A, Miyakawa Y, Mayumi M: Nucleotide sequence of the genomic RNA of hepatitis C virus isolated from a human carrier: Comparison with reported isolates for conserved and divergent regions. J Gen Virol 1991;72: 2697-2704.
204. Takamizawa A, Mori C, Fuke I, Manabe S, Murakami S, Fujita J, Onishi E, Andoh T, Yoshida I, Okayama H: Structure and organization of the hepatitis C virus genome isolated from human carriers. J Virol 1991;65:1105-1113.
205. Kolykhalov AA, Feinstone SM, Rice CM: Identification of a highly conserved sequence element at the 3′ terminus of hepatitis C virus genome RNA. J Virol 1996;70:3363-3371.
206. Tanaka T, Kato N, Cho M-J, Shimotohno K: A novel sequence found at the 3′ terminus of hepatitis C virus genome. Biochem Biophys Res Commun 1995;215:744-749.
207. Tanaka T, Kato N, Cho M-J, Sugiyama K, Shimotohno K: Structure of the 3′ terminus of the hepatitis C virus genome. J Virol 1996;70:3307-3312.
208. Yamada N, Tanihara K, Takada A, Yorihuzi T, Tsutsumi M, Shimomura H, Tsuji T, Date M: Genetic organization and diversity of the 3′ noncoding region of the hepatitis C virus genome. Virology 1996;223:255-261.
209. Chen P-J, Lin M-H, Tai K-F, Liu P-C, Lin C-J, Chen D-S: The Taiwanese hepatitis C virus genome: Sequence determination and mapping the 5′ termini of viral genomic and antigenomic RNA. Virology 1992;188:102-113.
210. Umlauft F, Wong DT, Oefner PJ, Underhill PA, Cheung RC, Wright TL, Kolykhalov AA, Gruenewald K, Greenberg HB: Hepatitis C virus detection by single-round PCR specific for the terminal 3′ noncoding region. J Clin Microbiol 1996;34:2552-2558.
211. Blight KJ, Gowans EJ: In situ hybridization and immunohistochemical staining of hepatitis C virus products. Viral Hepatitis Rev 1995;1:143-155.
212. Bertolini L, Iacovacci S, Ponzetto A, Gorini G, Battaglia M, Carloni G: The human bone-marrow-derived B-cell line CE, susceptible to hepatitis C virus infection. Res Virol 1993;144:281-285.
213. Nakajima N, Hijikata M, Yoshikura H, Shimizu YK: Characterization of long-term cultures of hepatitis C virus. J Virol 1996;70:3325-3329.
214. Valli MB, Bertolini L, Iacovacci S, Ponzetto A, Carloni G: Detection of a 5′ UTR variation in the HCV genome after long-term in vitro infection. Res Virol 1995;146:285-288.
215. Kato N, Nakazawa T, Mizutani T, Shimotohno K: Susceptibility of human T-lymphotropic virus type I infected cell line MT-2 to hepatitis C virus infection. Biochem Biophys Res Commun 1995; 206:863-869.
216. Mizutani T, Kato N, Saito S, Ikeda M, Sugiyama K, Shimotohno K: Characterization of hepatitis C virus replication in cloned cells obtained from a human T-cell leukemia virus type 1-infected cell line, MT-2. J Virol 1996;70:7219-7223.
217. Mizutani T, Kato N, Ikeda M, Sugiyama K, Shimotohno K: Long-term human T-cell culture system supporting hepatitis C virus replication. Biochem Biophys Res Commun 1996;227:822-826.
218. Shimizu YK, Iwamoto A, Hijikata M, Purcell RH, Yoshikura H: Evidence for in vitro replication of hepatitis C virus genome in a human T-cell line. Proc Natl Acad Sci USA 1992;89:5477-5481.
219. Shimizu YK, Purcell RH, Yoshikura H: Correlation between the infectivity of hepatitis C virus in vivo and its infectivity in vitro. Proc Natl Acad Sci USA 1993;90:6037-6041.
220. Shimizu Y, Yoshikura H: Multicycle infection of hepatitis C virus in cell culture and inhibition by alpha and beta interferons. J Virol 1994;68:8406-8408.
221. Kato N, Ikeda M, Mizutani T, Sugiyama K, Noguchi M, Hirohashi S, Shimotohno K: Replication of hepatitis C virus in cultured non-neoplastic human hepatocytes. Jpn J Cancer Res 1996;87: 787-792.
222. Tagawa M, Kato N, Yokosuka O, Ishikawa T, Ohto M, Omata M: Infection of human hepatocyte cell lines with hepatitis C virus in vitro. J Gastroenterol Hepatol 1995;10:523-527.
223. Cribier B, Schmitt C, Bingen A, Kim A, Keller F: In vitro infection of peripheral blood mononuclear cells by hepatitis C virus. J Gen Virol 1995;76:2485-2491.
224. Carloni G, Iacovacci S, Sargiacomo M, Ravagnan G, Ponzetto A, Peschle C, Battaglia M: Susceptibility of human liver cell cultures to hepatitis C virus infection. Arch Virol 1993;(suppl 8):31-39.
225. Iacovacci S, Sargiacomo M, Parolini I, Ponzetto A, Peschle C, Carloni G: Replication and multiplication of hepatitis C virus genome in human foetal liver cells. Res Virol 1993;144:275-279.
226. Lanford RE, Sureau C, Jacob JR, White R, Fuerst TR: Demonstration of in vitro infection of chimpanzee hepatocytes with hepatitis C virus using strand-specific RT/PCR. Virology 1994;202: 606-614.
227. Ito T, Mukaigawa J, Zuo J, Hirabayashi Y, Mitamura K, Yasui K: Cultivation of hepatitis C virus in primary hepatocyte culture from patients with chronic hepatitis C results in release of high titre infectious virus. J Gen Virol 1996;77:1043-1054.
228. Yoo BJ, Selby M, Choe J, Suh BS, Choi SH, Joh JS, Nuovo GJ, Lee H-S, Houghton M, Han JH: Transfection of a differentiated human hepatoma cell line (Huh7) with in vitro-transcribed hepatitis C virus (HCV) RNA and establishment of a long-term culture persistently infected with HCV. J Virol 1995;69:32-38.
229. Mills J, Volberding PA, Corey L: Antiviral Chemotherapy 4. New Directions for Clinical Applications and Research. Advances in Experimental Medicine and Biology. New York, Plenum Press, 1996, vol 394.
230. Alt M, Renz R, Hofschneider PH, Paumgartner G, Caselmann WH: Specific inhibition of hepatitis C viral gene expression by antisense phosphorothioate oligodeoxynucleotides. Hepatology 1995;22: 707-717.
231. Seki M, Honda Y: Phosphorothioate antisense oligodeoxynucleotides capable of inhibiting hepatitis C virus gene expression: In vitro translation assay. J Biochem 1995;118:1199-1204.
232. Vidalin O, Major ME, Rayner B, Imbach J-L, Trépo C, Inchauspé G: In vitro inhibition of hepatitis C virus gene expression by chemically modified antisense oligodeoxynucleotides. Antimicrob Agents Chemother 1996;40:2337-2344.
233. Wakita T, Wands JR: Specific inhibition of hepatitis C virus expression by antisense oligodeoxynucleotides. J Biol Chem 1994;269:14205-14210.
234. Mizutani T, Kato N, Hirota M, Sugiyama K, Murakami A, Shimotohno K: Inhibition of hepatitis C virus replication by antisense oligonucleotide in culture cells. Biochem Biophys Res Commun 1995;212:906-911.
235. Hanecak R, Brown-Driver V, Fox MC, Azad RF, Furusako S, Nozaki C, Ford C, Sasmor H, Anderson KP: Antisense oligonucleotide inhibition of hepatitis C virus gene expression in transformed hepatocytes. J Virol 1996;70:5203-5212.